Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

PAS Hemorrhage Risk

PAS Spectrum Risk

Placenta Accreta / Increta / Percreta Assessment

High-Yield Ultrasound Markers

  • Prior Cesarean Section (Weighted Rank 1)
  • Placenta Previa (Co-existing)
  • Multiple Placental Lacunae
  • Loss of retroplacental clear zone
  • Abnormal uterine-bladder interface
  • Exophytic mass (Extra-uterine extension)

Massive Transfusion (MTP)

WHO/FIGO Aligned Protocol: 1:1:1 Ratio (RBC : FFP : Platelets).

Hb Target> 7g/dL
Plt Target> 50k
Fib Target> 200mg/dL
Critical Bleeding RateExceeding 150mL / Minute
Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Primary Clinical Uses

Classifying the profound morbidity risk in patients presenting with placenta previa and prior cesarean sections.
Directing surgical planning (e.g., scheduled cesarean hysterectomy, massive transfusion protocols).
Pre-operative counseling regarding the extreme risk of catastrophic pelvic hemorrhage.

What is PAS?

Placenta Accreta Spectrum (PAS) involves abnormal trophoblast invasion into the myometrium. It is categorized into Accreta (attaches directly to myometrium), Increta (invades into myometrium), and Percreta (penetrates through serosa/bladder).

Last Comprehensive Review: 2026